Short bowel syndrome

Parenteral nutrition versus intestinal transplantation. Where are we today?

Mark DeLegge, Mohammad M. Alsolaiman, English Barbour, Samah Bassas, M. Faisal Siddiqi, Nicole M Moore

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Current management of short bowel syndrome (SBS) revolves around the use of home TPN (HPN). Complications include liver disease, catheter-related infections or occlusions, venous thrombosis, and bone disease. Patient survival with SBS on TPN is 86% and 75% at 2 and 5 years, respectively. Surgical management of SBS includes nontransplant surgeries such as serial transverse enteroplasty and reanastomosis. Small bowel transplant has become increasingly popular for management of SBS and is usually indicated when TPN cannot be continued. Posttransplant complications include graft-versus-host reaction, infections in an immunocompromised patient, vascular and biliary diseases, and recurrence of the original disease. Following intestinal-only transplants, patient and graft survival rate is 77% and 66% after 1 year. After 5 years the survival figures are 49% and 34%, respectively. Future improvements in survival and quality of life will enhance small bowel transplant as a viable treatment option for patients with SBS.

Original languageEnglish (US)
Pages (from-to)876-892
Number of pages17
JournalDigestive Diseases and Sciences
Volume52
Issue number4
DOIs
StatePublished - Apr 1 2007
Externally publishedYes

Fingerprint

Short Bowel Syndrome
Parenteral Nutrition
Transplantation
Transplants
Survival
Catheter-Related Infections
Bone Diseases
Immunocompromised Host
Graft Survival
Vascular Diseases
Venous Thrombosis
Liver Diseases
Survival Rate
Quality of Life
Recurrence
Infection

Keywords

  • Parenteral nutrition
  • Short bowel syndrome
  • Small intestine
  • Transplantation

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Cite this

Short bowel syndrome : Parenteral nutrition versus intestinal transplantation. Where are we today? / DeLegge, Mark; Alsolaiman, Mohammad M.; Barbour, English; Bassas, Samah; Siddiqi, M. Faisal; Moore, Nicole M.

In: Digestive Diseases and Sciences, Vol. 52, No. 4, 01.04.2007, p. 876-892.

Research output: Contribution to journalArticle

DeLegge, Mark ; Alsolaiman, Mohammad M. ; Barbour, English ; Bassas, Samah ; Siddiqi, M. Faisal ; Moore, Nicole M. / Short bowel syndrome : Parenteral nutrition versus intestinal transplantation. Where are we today?. In: Digestive Diseases and Sciences. 2007 ; Vol. 52, No. 4. pp. 876-892.
@article{20169ec542714770bdf4c87a5c7f8cbb,
title = "Short bowel syndrome: Parenteral nutrition versus intestinal transplantation. Where are we today?",
abstract = "Current management of short bowel syndrome (SBS) revolves around the use of home TPN (HPN). Complications include liver disease, catheter-related infections or occlusions, venous thrombosis, and bone disease. Patient survival with SBS on TPN is 86{\%} and 75{\%} at 2 and 5 years, respectively. Surgical management of SBS includes nontransplant surgeries such as serial transverse enteroplasty and reanastomosis. Small bowel transplant has become increasingly popular for management of SBS and is usually indicated when TPN cannot be continued. Posttransplant complications include graft-versus-host reaction, infections in an immunocompromised patient, vascular and biliary diseases, and recurrence of the original disease. Following intestinal-only transplants, patient and graft survival rate is 77{\%} and 66{\%} after 1 year. After 5 years the survival figures are 49{\%} and 34{\%}, respectively. Future improvements in survival and quality of life will enhance small bowel transplant as a viable treatment option for patients with SBS.",
keywords = "Parenteral nutrition, Short bowel syndrome, Small intestine, Transplantation",
author = "Mark DeLegge and Alsolaiman, {Mohammad M.} and English Barbour and Samah Bassas and Siddiqi, {M. Faisal} and Moore, {Nicole M}",
year = "2007",
month = "4",
day = "1",
doi = "10.1007/s10620-006-9416-6",
language = "English (US)",
volume = "52",
pages = "876--892",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Short bowel syndrome

T2 - Parenteral nutrition versus intestinal transplantation. Where are we today?

AU - DeLegge, Mark

AU - Alsolaiman, Mohammad M.

AU - Barbour, English

AU - Bassas, Samah

AU - Siddiqi, M. Faisal

AU - Moore, Nicole M

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Current management of short bowel syndrome (SBS) revolves around the use of home TPN (HPN). Complications include liver disease, catheter-related infections or occlusions, venous thrombosis, and bone disease. Patient survival with SBS on TPN is 86% and 75% at 2 and 5 years, respectively. Surgical management of SBS includes nontransplant surgeries such as serial transverse enteroplasty and reanastomosis. Small bowel transplant has become increasingly popular for management of SBS and is usually indicated when TPN cannot be continued. Posttransplant complications include graft-versus-host reaction, infections in an immunocompromised patient, vascular and biliary diseases, and recurrence of the original disease. Following intestinal-only transplants, patient and graft survival rate is 77% and 66% after 1 year. After 5 years the survival figures are 49% and 34%, respectively. Future improvements in survival and quality of life will enhance small bowel transplant as a viable treatment option for patients with SBS.

AB - Current management of short bowel syndrome (SBS) revolves around the use of home TPN (HPN). Complications include liver disease, catheter-related infections or occlusions, venous thrombosis, and bone disease. Patient survival with SBS on TPN is 86% and 75% at 2 and 5 years, respectively. Surgical management of SBS includes nontransplant surgeries such as serial transverse enteroplasty and reanastomosis. Small bowel transplant has become increasingly popular for management of SBS and is usually indicated when TPN cannot be continued. Posttransplant complications include graft-versus-host reaction, infections in an immunocompromised patient, vascular and biliary diseases, and recurrence of the original disease. Following intestinal-only transplants, patient and graft survival rate is 77% and 66% after 1 year. After 5 years the survival figures are 49% and 34%, respectively. Future improvements in survival and quality of life will enhance small bowel transplant as a viable treatment option for patients with SBS.

KW - Parenteral nutrition

KW - Short bowel syndrome

KW - Small intestine

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=33947590630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947590630&partnerID=8YFLogxK

U2 - 10.1007/s10620-006-9416-6

DO - 10.1007/s10620-006-9416-6

M3 - Article

VL - 52

SP - 876

EP - 892

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 4

ER -